TipRanks
55% OFF
PC:RACTI

Ractigen Therapeutics

Clinical-stage biotechnology company pioneering small activating RNA (saRNA) therapeutics and advanced extrahepatic RNA delivery systems. Focused on developing saRNA candidates for systemic and CNS indications and advancing proprietary delivery platforms to enable extrahepatic targeting.

Leadership & Board

Latest Estimated Valuation

Estimated Valuation
―
Total Amount Raised
$31M
Total Funding Rounds
1
Latest Funding Amount
$31M
Latest Funding Round
Investment
Post-Money Valuation
―

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Jul 29, 2026Investment$31.00M―

Investors

Investor NameFunding Round
Guozhong CapitalInvestment

Similar Companies

A snapshot of private companies similar to Ractigen Therapeutics, helping you discover and navigate related company profiles.

Related News and Analysis